Intelligence Platform

Patents

Browse 2,465 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

US 10350273

Treatment of hormonal disorders of growth

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10350228

Treatment of sickle cell disease and inflammatory conditions

Regents of the University of Minnesota · Granted Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10351589

3.alpha.-ethynyl, 3.beta.-hydroxy-5.alpha.-pregnan-20-oxime for use in the treatment of CN

Umecrine Cognition AB · Granted Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10350183

Intravenous baclofen formulations and treatment methods

Regents of the University of Minnesota · Granted Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10342786

P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD

Fulcrum Therapeutics, Inc. · Granted Tue Jul 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10342804

Steroid compound for use in the treatment of hepatic encephalopathy

Umecrine Cognition AB · Granted Tue Jul 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10342815

GLA monotherapy for use in cancer treatment

IMMUNE DESIGN CORP. · Granted Tue Jul 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10335466

AADC polynucleotides for the treatment of parkinson's disease

VOYAGER THERAPEUTICS, INC. · Granted Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10330685

Markers for sepsis treatment

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jun 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10327853

System and method of performing treatment along a lumen network

Covidien LP · Granted Tue Jun 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10322124

6-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive ai

Sulfateq B.V. · Granted Tue Jun 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10322113

Pharmaceutical compositions directly targeting FKBP52 for the treatment of prostate cancer

The Board of Regents of the University of Texas System · Granted Tue Jun 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10322129

Therapeutic compositions containing dipyridamole, treatment packs and kits including such

O.D. Ocular Discovery Ltd. · Granted Tue Jun 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10314885

Oxytocin treatment to modify blood glucose and treat metabolic disease

The Regents of the University of California · Granted Tue Jun 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10314850

Use of ACTH in assessment and prophylactic treatment of hypokalemia associated with glucoc

Corcept Therapeutics Incorporated · Granted Tue Jun 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10308617

Triazole benzamide derivatives and the compositions and methods of treatment regarding the

AN2H DISCOVERY LIMITED · Granted Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10307477

Methods for inducing an immune response against human immunodeficiency virus infection in

The United States of America as represented by the Secretary of the Army · Granted Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10307437

Methods for treatment of vascular endothelial dysfunction using nicotinamide mononucleotid

The Regents of the University of Colorado, a Body Corporate · Granted Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10307469

Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10307410

Mcl-1 modulating compounds for cancer treatment

INSTITUT DE CANCEROLOGIE DE L'OUEST RENE GAUDUCHEAU · Granted Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10307388

Compositions and methods for diagnosis and treatment of inflammation

United States of America as represented by the Secretary of the Air Force · Granted Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10307418

Azole pharmaceutical formulations for parenteral administration and methods for preparing

Platform Brightworks Two, Ltd. · Granted Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10301314

Compounds and methods for the prevention and treatment of tumor metastasis and tumorigenes

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10300047

Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid for the tre

PTC THERAPEUTICS, INC. · Granted Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)